Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female and at least 19 years old
- People who have been diagnosed with HER2-positive invasive breast cancer, confirmed through laboratory testing of tissue
- People whose general health and ability to carry out daily activities falls within a certain range (a scale used by doctors to measure how well a patient is functioning — confirm with trial site)
- People who have given their informed consent to participate
Who may not be able to join:
- People whose breast cancer has been confirmed as ductal carcinoma in situ (an early-stage, non-invasive form of breast cancer that stays within the milk ducts)
- People who have previously had radiation therapy to the same breast being treated
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haeyoung Kim, MD, PhD, Samsung Medical Center
Phone: 82-2-3410-2612
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Ipsilateral breast tumor recurrence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.